ACADEMIC RADIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2022-11-11 今天审稿人爸爸心情好了吗

审稿速度:1.0 | 投稿命中率:50.0
经验分享：10.13 submit
11.2 major
11.10 re-submit

222 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2024-04-15 ms8000000162197703 来自重庆

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：MRI;妇科影像
经验分享：3.17 submission
3.19 with editor
3.21 under review
4.1 Major revision
4.10 Revision Submitted
4.12 with editor
4.12 Minor revision
4.14 Revision Submitted
4.14 Accept
从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！

123 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2024-10-09 ms8000000121798389 来自浙江省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：影像组学;肿瘤
经验分享：2024.07.16 投稿
2024.07.17 格式问题重新提交
2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人）
2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题
2024.08.05 返回修改意见，并提交修改稿
2024.08.14 接收accepted for publication
从提交到接受不到一个月，神速！

49 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2022-10-26 12114defm22(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0
经验分享：别选OA，发在了增刊上。

232 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2025-03-27 ms4000000630574235 来自江苏省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：杂志很好

8 0

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2020-02-14 Hanwin

审稿速度:1.0 | 投稿命中率:50.0
经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了

363 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2024-04-09 ms7000001717279760 来自安徽省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：影像组学;宫颈癌;IVIM-DWI
经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。

106 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2024-12-12 ms1000000156932611 来自陕西省

为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？

12 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2022-02-08 ms6000000933123975

偏重的研究方向：影响医学与核医学
经验分享：杂志社处理的很快，给我推荐了转投杂志😂

170 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2241970, encodeId=643f22419e0b3, content=为什么我投稿后直接decision in progress了，都没有with editor，这正常吗，是不是预示被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=818e9456738, createdName=ms1000000156932611, createdTime=Thu Dec 12 09:47:24 CST 2024, time=2024-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向：影响医学与核医学 经验分享：杂志社处理的很快，给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2233977, encodeId=caea22339e722, content=问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d208711663, createdName=ms8000001764716829, createdTime=Tue Oct 29 19:38:15 CST 2024, time=2024-10-29, status=1, ipAttribution=山西省)]

2024-10-29 ms8000001764716829 来自山西省

问下大家submit 之后大概多会会with editor啊，而且也没收到什么确认稿件的邮件啊

39 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务